REACTIVO PARA LA DETERMINACIÓN DE COLESTEROL EN SUERO O EN PLASMA HUMANO
Mexico·Clase I·III. Agentes de diagnóstico·ABBOTT
LABORATORIES DE
MÉXICO, S.A. DE C.V.·Registered December 06, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ARCHITECT CHOLESETROL
- Trade Name (English)
- ARCHITECT CHOLESETROL
- Analysis ID
- 1523R2022 SSA
- Registration Date
- December 06, 2022
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for REACTIVO PARA LA DETERMINACIÓN DE COLESTEROL EN SUERO O EN PLASMA HUMANO (REACTIVO PARA LA DETERMINACIÓN DE COLESTEROL EN SUERO O EN PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1523R2022 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 06, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.